Cargando…
Novel prognostic marker PRMT1 regulates cell growth via downregulation of CDKN1A in HCC
Hepatocellular carcinoma (HCC) is a major type of liver cancer caused by the hepatitis B and C viruses, alcohol and exposure to aflatoxin. For HCC treatment, anticancer drugs have been widely used, but drug resistance in advanced HCC is an important problem, resulting in a continuous need for novel...
Autores principales: | Ryu, Jea-Woon, Kim, Seon-Kyu, Son, Mi-Young, Jeon, Su-Jin, Oh, Jung-Hwa, Lim, Jung Hwa, Cho, Sunwha, Jung, Cho-Rok, Hamamoto, Ryuji, Kim, Dae-Soo, Cho, Hyun-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777784/ https://www.ncbi.nlm.nih.gov/pubmed/29383172 http://dx.doi.org/10.18632/oncotarget.23296 |
Ejemplares similares
-
EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression
por: Lee, Jinkwon, et al.
Publicado: (2021) -
The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2018) -
Downregulation of PRMT1, a histone arginine methyltransferase, by sodium propionate induces cell apoptosis in colon cancer
por: Ryu, Tae Young, et al.
Publicado: (2019) -
SETDB1 regulates SMAD7 expression for breast cancer metastasis
por: Ryu, Tae Young, et al.
Publicado: (2019) -
Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis
por: Kim, Kwangho, et al.
Publicado: (2023)